navbar brand navbar brand
  • Course Catalog
  • Event Calendar
  • Contact Us

You are being redirected to another site.


Back to Post List
New Post
Title(*)
Description
  • Introduction
Click on the on the top progress bar to review the step.
MDS-ES Tailored and Innovative Pump Therapies for Parkinson's Disease
Course Format
Regional In-Person Course
Start Date
Fri, Jun 2, 2023
End Date
Sat, Jun 3, 2023
...
Program Description

The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease course will provide theoretical education and practical experience in the management of pump therapies for advanced Parkinson’s disease (Levodopa carbidopa intestinal gel and apomorphine). Additionally, the course will include innovations in the infusion therapies field e.g. Levodopa-Entacapone-Carbidopa Intestinal Gel and subcutaneous levodopa pumps. The course includes lectures on the development of the therapies, their experimental basis, effects and side effects, practical management, interactive workshops on patient selection and practical management, as well as a hands-on course on pump management.

By registering for this course, you agree to the statement provided in the section below labeled 'Assumption of Risk and Liability - COVID'.

You cannot participate in this course
Registration is now closed. If you are interested in registering, please email education@movementdisorders.org.
Faculty

Course Directors

Katarzyna Smilowska, MD, PhD - Department of Neurology, Silesian Center of Neurology, Katowice, Poland

Tove Henriksen, MD - Bispebjerg Hospital, Copenhagen, Denmark

Faculty

Angelo Antonini, MD, PhD - University of Padua, Padua, Italy

Marek Balaz, MD, PhD - St. Anne's University Hospital, Brno, Czech Republic
Bas Bloem, MD, PhD, FRCPE, Radboud University Medical Center, Nijmegen, Netherlands

K. Ray Chaudhuri, FRCP, DSc, FEAN - King's College, London, United Kingdom

Per Odin, MD, PhD - Lund University, Lund, Sweden

Miriam Parry - King's College Hospital NHS Trust, London, United Kingdom

Karolina Poplawska-Domaszewicz, MD, PhD - Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland

Anna Roszmann, PhD, MA, RN - Medical University of Gdansk, Gdansk, Poland

Matej Škorvánek, MD, PhD - University of P. J. Safarik, Košice, Slovakia

Learning Objectives

Upon completion of this activity, learners will be able to:

1. Describe the theoretical evidence supporting CDS-based treatment
2. Define the criteria and process of selecting patients for pump therapies
3. Summarize the effects of pump therapies on motor, non-motor symptoms and quality of life based on new EAN/MDS-ES Guidelines
4. Demonstrate management of pump therapies including hands-on workshop on the pump management
5. Identify possible side effects and complications of advanced therapies, including management of these complications

Method of Participation

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Accreditation and Credit Designation

Accreditation Statement
The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease, Katowice, Poland, 02/06/2023-03/06/2023 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Supporter Information

The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease course wishes to acknowledge the following commercial supporters and exhibitors:


AbbVie
Britannia

Funding Statement

The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease course has received unrestricted medical education grants from the following companies:


EVER Pharma Poland

Contact Us
MDS Education
education@movementdisorders.org
MDS Secretariat Liaison

Allie Oakley Stoffel

Venue

Venue

Courtyard Marriott Katowice City Center
Ul. Uniwersytecka 13, 40-007 Katowice, Poland

Meeting Room
Madagaskar 2-3

Assumption of Risk and Liability - COVID

Attendee assumes all risks and accepts sole responsibility for any injury (including, but not limited to, personal injury, disability, and death), illness, damage, loss, claim, liability or expense, of any kind, that they may experience or incur in connection with attending the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease.


The International Parkinson and Movement Disorder Society’s European Section (MDS-ES) has taken preventative measures to reduce the spread of communicable disease including, but not limited to COVID-19 (“Communicable Disease”) at the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease. However, MDS cannot guarantee that attendees will not be exposed to or contract a Communicable Disease at the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease. Further, due to the nature of the facilities, services and programs offered at the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease, participants understand that attending the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease could increase their risk of contracting a Communicable Disease.


Attendee agrees to abide by all applicable COVID-19-related requirements, advisories, policies, procedures, and protocols of the hotel and MDS-ES as well as the Centers for Disease Control and Prevention (CDC), the city of Katowice, Poland, and any other governmental authority for the duration of their stay.


Attendee understands the risk that they may be exposed to or infected by a Communicable Disease by attending the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease and that such exposure or infection may result in quarantine requirements, serious illness, permanent disability and/or death. Attendee further understands that the risk of becoming exposed to or infected by a Communicable Disease at the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease may result from the actions, omissions or negligence of themselves and others, including, but not limited to, MDS-ES, its officers, employees, contractors, agents, representatives, sponsors, other participants, and any owners and lessors of premises used to conduct the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease (“Releasees”). ATTENDEE KNOWINGLY AND FREELY ASSUMES ALL SUCH RISKS, BOTH KNOWN AND UNKNOWN, EVEN IF ARISING FROM THE NEGLIGENCE OF THE RELEASEES, and assumes full responsibility for their participation in the MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease.

Ethical MedTech

The MDS-ES Tailored and Innovative Pump Therapies for Parkinson’s Disease course is assessed as COMPLIANT with the MedTech Europe Code of Ethical Business Practice and EFPIA Code of Practice.

This decision is available here: https://www.ethicalmedtech.eu/medtech-apps/cvs/view-event/EMT32938.

Course Lectures & Supplemental Materials

DAY 1 Lectures
1.1 Advanced Parkinson's Disease Clinical Definition and New Recommendations - Tove Henriksen.pdf
1.2 Multidisciplinary Team Management & Organization - Miriam Parry.pdf
1.6 Apomorphine and Effects on Motor Symptoms - Karolina Poplawska-Domaszewicz.pdf
1.7 Non Motor Symptoms Apomorphine in PD - K. Ray Chaudhuri.pdf
1.9 LCIG and LECIG and Effects on Motor Symptoms - Katarzyna Smilowska.pdf
1.10 Levodopa-Carbidopa Intestinal Gel & LECIG and Effects on Non Motor Symptoms - K. Ray Chaudhuri.pdf
1.12 Innovations in the Infusion Therapies Field - Matej Skorvanek.pdf

DAY 2 Lectures
2.1 How to Start LCIG - Katarzyna Smilowska.pdf
2.3 Management of Patients with Pump Infusion Therapies - Miriam Parry.pdf
2.4 Patient Selection - Tove Henriksen.pdf
2.5 Multidisciplinary Parkinson’s Disease Research - K. Ray Chaudhuri.pdf

Certificate Claiming Instructions

The course evaluation and certificate of attendance are available online. To access:

  1. Visit https://education.movementdisorders.org.
  2. Click “GET CERTIFICATE” in the upper right corner.
  3. Once prompted enter the certificate code (640510). You will be prompted to fill out your course evaluation and upon completion, you will be able to download your certificate of attendance.

Course Program & Schedule

23ESPUMP Final Program.pdf
A copy will be available onsite.

Copyright © 1998-2025 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved.

Processing...
×